Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck

Go back to Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 107.62 +2.73 (2.60%)
Previous Close $104.89    52 Week High $18.39 
Open $106.39    52 Week Low $6.96 
Day High $107.96    P/E N/A 
Day Low $105.50    EPS $-0.58 
Volume 2,415,555       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1280.34 +54.61 (4.46%)
Previous Close $1225.73    52 Week High $88.16 
Open $1245.81    52 Week Low $67.88 
Day High $1292.65    P/E 296.38 
Day Low $1240.54    EPS $4.32 
Volume 4,378,466       

Medtronic Inc. (NYSE: MDT) Delayed: 94.13 +2.04 (2.22%)
Previous Close $92.09    52 Week High $89.27 
Open $92.38    52 Week Low $71.03 
Day High $94.72    P/E 26.74 
Day Low $91.95    EPS $3.52 
Volume 5,630,712       

NOVO-NORDISK A/S (NYSE: NVO) Delayed: 46.48 +0.77 (1.68%)
Previous Close $45.71    52 Week High $59.00 
Open $46.01    52 Week Low $32.80 
Day High $47.20    P/E N/A 
Day Low $45.84    EPS $0.00 
Volume 15,690,024       

SANOFI (NASDAQ: SNY) Delayed: 45.83 +0.86 (1.91%)
Previous Close $44.97    52 Week High $44.76 
Open $45.42    52 Week Low $36.81 
Day High $46.02    P/E N/A 
Day Low $45.42    EPS $0.00 
Volume 2,737,836